Literature DB >> 2315949

Determination of the effect of tridiphane on the pharmacokinetics of [14C]-atrazine following oral administration to male Fischer 344 rats.

C Timchalk1, M D Dryzga, P W Langvardt, P E Kastl, D W Osborne.   

Abstract

The absorption, distribution, metabolism and excretion of [14C]-atrazine was studied in male Fischer 344 rats administered a 30 mg [14C]-atrazine/kg of body weight oral dose with or without pretreatment with a non-radiolabeled oral dose of 60 mg tridiphane/kg of body weight. The objective of this study was to determine whether tridiphane had any meaningful effect on the pharmacokinetics and/or metabolism of atrazine in the rat. The 14C plasma time-course exhibited a mono-exponential decrease with an absorption and elimination half-life of approximately 3 h and 11 h, respectively for both treatment groups. In addition, at 72 h after the administration of [14C]-atrazine, approximately 93% of the administered radioactivity was recovered and the primary route of excretion was via the urine (67%) for both treatment groups. The feces accounted for approximately 18% of the dose, and less than 10% remained in the carcass, skin, and red blood cells (RBCs). The urine excreted in the first 24 h post-dosing contained approximately 57% of the administered radioactivity for both treatment groups. There were no appreciable differences in the metabolite distribution between treatment groups, and the major urinary metabolite of atrazine was found to be 2-chloro-4,6-diamino-1,3,5-triazine (II; 64-67%). Additionally, S-(2-amino-4-methylethylamino-1,3,5-triazin-6-yl)-mercapturi c acid (V; 13-14%), and S-(2,4-diamino-1,3,5-triazin-6-yl)-mercapturic acid (III; 9%) were tentatively identified based upon similar HPLC retention times as seen with synthesized standards. These data indicate that there are no meaningful differences in the absorption, distribution, metabolism, and excretion between rats administered only [14C]-atrazine and those administered both tridiphane and [14C]-atrazine. Therefore, it can be concluded that tridiphane has no meaningful effect on the pharmacokinetics and/or metabolism of atrazine in the rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315949     DOI: 10.1016/0300-483x(90)90004-z

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  5 in total

1.  Metabolic profile of atrazine and N-nitrosoatrazine in rat urine.

Authors:  G Meli; R Bagnati; R Fanelli; E Benfenati; L Airoldi
Journal:  Bull Environ Contam Toxicol       Date:  1992-05       Impact factor: 2.151

2.  Two-dimensional high performance liquid chromatography separation and tandem mass spectrometry detection of atrazine and its metabolic and hydrolysis products in urine.

Authors:  Zsuzsanna Kuklenyik; Parinya Panuwet; Nayana K Jayatilaka; James L Pirkle; Antonia M Calafat
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-06-02       Impact factor: 3.205

3.  Patterns of immunotoxicity associated with chronic as compared with acute exposure to chemical or physical stressors and their relevance with regard to the role of stress and with regard to immunotoxicity testing.

Authors:  Stephen B Pruett; Ruping Fan; Qiang Zheng; Carlton Schwab
Journal:  Toxicol Sci       Date:  2009-04-07       Impact factor: 4.849

4.  Presence of atrazine in the biological samples of cattle and its consequence adversity in human health.

Authors:  Sz Peighambarzadeh; S Safi; Sj Shahtaheri; M Javanbakht; A Rahimi Forushani
Journal:  Iran J Public Health       Date:  2011-12-31       Impact factor: 1.429

5.  PBPK Model for Atrazine and Its Chlorotriazine Metabolites in Rat and Human.

Authors:  Jerry L Campbell; Melvin E Andersen; Paul M Hinderliter; Kun Don Yi; Timothy P Pastoor; Charles B Breckenridge; Harvey J Clewell
Journal:  Toxicol Sci       Date:  2016-01-21       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.